Sort   by:  
 Page size 
UnknownDisease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset.
Not available
S-EPMC12007600 | biostudies-literature
UnknownImpaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey.
Not available
S-EPMC10960935 | biostudies-literature
UnknownHigh fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey.
Not available
S-EPMC10265550 | biostudies-literature
UnknownSystemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey.
Not available
S-EPMC10064600 | biostudies-literature
UnknownCOVAD survey 2 long-term outcomes: unmet need and protocol.
Not available
S-EPMC9376047 | biostudies-literature
UnknownLong-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study.
Not available
S-EPMC10348925 | biostudies-literature
UnknownCOVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study.
Not available
S-EPMC9214139 | biostudies-literature
UnknownSafety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.
Not available
S-EPMC10321116 | biostudies-literature
UnknownHigher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study.
Not available
S-EPMC9620363 | biostudies-literature
UnknownCOVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey.
Not available
S-EPMC11618185 | biostudies-literature
Sort   by:  
 Page size